Expanded Accessibility is a potential pathway for a individual with a serious or immediately everyday living-threatening sickness or affliction to realize entry to an investigational healthcare item (drug, biologic, or clinical unit) for treatment beyond clinical trials when no equivalent or satisfactory substitute therapy solutions can be obtained